0001493152-24-010645.txt : 20240320
0001493152-24-010645.hdr.sgml : 20240320
20240320142452
ACCESSION NUMBER: 0001493152-24-010645
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
EFFECTIVENESS DATE: 20240320
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: bioAffinity Technologies, Inc.
CENTRAL INDEX KEY: 0001712762
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 465211056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-508127
FILM NUMBER: 24767395
BUSINESS ADDRESS:
STREET 1: 22211 WEST INTERSTATE-10
STREET 2: SUITE 1206
CITY: SAN ANTONIO
STATE: TX
ZIP: 78257
BUSINESS PHONE: 210-698-5334
MAIL ADDRESS:
STREET 1: 22211 WEST INTERSTATE-10
STREET 2: SUITE 1206
CITY: SAN ANTONIO
STATE: TX
ZIP: 78257
D
1
primary_doc.xml
X0708
D
LIVE
0001712762
bioAffinity Technologies, Inc.
22211 W. INTERSTATE 10
SUITE 1206
SAN ANONIO
TX
TEXAS
782257
(210) 698-5334
DELAWARE
None
None
Corporation
true
Maria
Zannes
22211 W. Interstate 10
Suite 1206
San Anonio
TX
TEXAS
782257
Executive Officer
Director
Michael
Dougherty
22211 W Interstate 10
Suite 1206
San Antonio
TX
TEXAS
78257
Executive Officer
Placement agent fee of 9% plus warrants to purchase 32,000 shares at an exercise price of $1.64.
Vivienne
Rebel
22211 W Interstate 10
Suite 1206
San Antonio
TX
TEXAS
78257
Executive Officer
Timothy
P.
Zannes
22211 W Interstate 10
Suite 1206
San Antonio
TX
TEXAS
78257
Executive Officer
Steven
Girgenti
22211 W Interstate 10
Suite
San Antonio
TX
TEXAS
78257
Executive Officer
Director
Roby
P.
Joyce
22211 W Interstate 10
Suite 1206
San Antonio
TX
TEXAS
78257
Director
Jamie
Platt
22211 W Interstate 10
Suite 1206
San Antonio
TX
TEXAS
78257
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-03-06
false
true
true
true
false
2624000
WallachBeth Capital LLC
147853
None
None
1001 YAMATO ROAD
SUITE 404
BOCA RATON
FL
FLORIDA
33431
CA
CALIFORNIA
NY
NEW YORK
false
2624000
2624000
0
Includes an aggregate exercise price of warrants of $1.64
false
3
225000
true
0
Placement agent fee of 9% plus warrants to purchase 32,000 shares at an exercise price of $1.64.
0
false
bioAffinity Technologies, Inc.
/s/ Maria Zannes
Maria Zannes
President & CEO
2024-03-20